Regorafenib for Recurrent Meningioma (MIRAGE Trial)
Regorafenib for Recurrent Meningioma (MIRAGE Trial)
Recruiting · NCT06275919 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Regorafenib for Recurrent Meningioma (MIRAGE Trial) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer | Recruiting | Phase 2 | 2026-09-30 | NCT06275919 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
| Istituto Oncologico Veneto IRCCS | 22 |
20 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.